🇺🇸 FDA
Patent

US 7776548

Endocytotic pathway delivery vehicle for targeting drugs and antibodies to prostate and other tissues

granted A61KA61K38/00

Quick answer

US patent 7776548 (Endocytotic pathway delivery vehicle for targeting drugs and antibodies to prostate and other tissues) held by The Regents of the University of California expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K38/00